how many people in the us are taking glp 1 According to poll, the share of U.S. adults currently GLP-1 medications for weight loss has climbed to 11% 2026, up from 3% just two years ago. 🔗⬇️ 11% OF AMERICANS ARE ON

Support the immune system : B12 contributes to a healthy immune system, helping the body fight infections

Semaglutide can cause dehydration due to gastrointestinal side effects, potentially leading to acute kidney injury

Foods with a high GI can lead to rapid spikes in blood sugar, followed by crashes that may increase hunger and lead to overeating

Summary: Current evidence does not establish a definitive causal relationship between weight loss injections (GLP-1 receptor agonists) and pancreatitis, though UK regulatory guidance lists pancreatitis as a potential adverse effect requiring monitoring

Bloating, gas, diarrhea, or constipation early on is usually just a sign that the probiotics are working to rebalance your microbiome

Recent research has revolutionized how we approach colonoscopy preparation, making it more effective and tolerable than ever before